Pillstats
Rx only · Injection · Intravenous

Etomidate

Etomidate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN01AX07
RxCUI (US)4177
US makers3 labelers
Packages7
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

661321982632025 Q12025 Q22025 Q32025 Q42026 Q1
209
Rx · 2026 Q1
1.4K
Units dispensed
-9%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hikma Pharmaceuticals USA Inc.unknown4SUPPLYING
Civica, Inc.unknown2SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 5, 2022
    SHORTAGEDrug shortage: Etomidate Injection (Hikma Pharmaceuticals USA, Inc.)

    Etomidate Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Anesthesia.